Michał Łomiak

Also affiliated with Instytut Hematologii i Transfuzjologi, Postgraduate School of Molecular Medicine

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC”.

Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c00577

N/A

0DataRank · unranked

8 citations

Dawid Mehlich, Venkata R. Sabbasani, Michał Łomiak, Pedro Torres‐Ayuso, Katarzyna Wróbel +6 more